General Information
Version
1.0 en
Revision date
2025-08-19
Product name
Rapamycin ≥95 %
CAS No.
53123-88-9
REACH No
It
1.2.1 Relevant identified uses
Laboratory and analytical use
1.2.2. Uses advised against
Do not use for products which come into contact with foodstuffs. Do not use for private purposes (household). Food, drink and animal feeding- stuffs
Icons in SDS
Company Information
company name
Carl Roth GmbH + Co. KG
e-mail address of the competent person responsible for the Safety Data Sheet
sicherheit@carlroth.de
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H351, H361, H372
Hazard statements
Code
Statements
H351
Suspected of causing cancer
Section 2
SECTION 2: Hazards identification
According to Regulation (EC) No 1272/2008 [CLP Classification of the substance or mixture
Hazard categories
Cat- Hazard class and Hazard egory category statement 3.6 Carcinogenicity Carc. 2 H351 3.7 Reproductive toxicity Repr. 2 H361 3.9 Specific target organ toxicity - repeated exposure STOT RE 1 H372 For full text of abbreviations: see SECTION 16
Most important adverse effects
Delayed or immediate effects can be expected after short or long-term exposure
Signal word
Danger Danger Not required
Hazard pictograms
GHS08 H351 Suspected of causing cancer. H361 Suspected of damaging fertility or the unborn child. H372 Causes damage to organs through prolonged or repeated exposure. P202 Do not handle until all safety precautions have been read and understood. P260 Do not breathe dust/fume/gas/mist/vapours/spray. P270 Do not eat, drink or smoke when using this product. P280 Wear protective gloves/protective clothing/eye protection/face protection. P308+P313 IF exposed or concerned: Get medical advice/attention. Labelling of packages where the contents do not exceed 10 ml
Hazard statements
H351 Suspected of causing cancer H361 Suspected of damaging fertility or the unborn child H372 Causes damage to organs through prolonged or repeated exposure Not required
Prevention
P201 Obtain special instructions before use P202 Do not handle until all safety precautions have been read and understood P260 Do not breathe dust/fume/gas/mist/vapours/spray P270 Do not eat, drink or smoke when using this product P280 Wear protective gloves/protective clothing/eye protection/face protection
Response
P308+P313 IF exposed or concerned: Get medical advice/attention For professional users only Labelling of packages where the contents do not exceed 125 ml
Precautionary statements
Not required
Results of PBT and vPvB assessment
According to the results of its assessment, this substance is not a PBT or a vPvB. Endocrine disrupting properties Does not contain an endocrine disruptor (ED) at a concentration of ≥ 0,1%.
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008 (CLP) Section Hazard class Cat- Hazard class and Hazard egory category statement 3.6 Carcinogenicity 2 Carc. 2 H351 3.7 Reproductive toxicity 2 Repr. 2 H361 3.9 Specific target organ toxicity - repeated exposure 1 STOT RE 1 H372 For full text of abbreviations: see SECTION 16 The most important adverse physicochemical, human health and environmental effects Delayed or immediate effects can be expected after short or long-term exposure.
